Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients

Diabetologia

Volumn 55, Issue 1, 2012, Pages 46-50

  Hendriksen, K V ^a   Jensen, T ^b   Oturai, P ^a   Feldt Rasmussen, B ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Blood pressure; Body weight; Extracellular fluid volume; Type 2 diabetes; Urinary sodium excretion

Indexed keywords

ALDOSTERONE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; INSULIN DETEMIR; ISOPHANE INSULIN; RENIN; SODIUM;

ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; EXTRACELLULAR SPACE; FLUID RETENTION; GLUCOSE BLOOD LEVEL; HUMAN; INJECTION SITE PRURITUS; LEAN BODY WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN PRURITUS; SODIUM URINE LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT GAIN; WEIGHT REDUCTION;

AGED; BODY COMPOSITION; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; EXTRACELLULAR FLUID; FLUID SHIFTS; GLOMERULAR FILTRATION RATE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN, ISOPHANE; INSULIN, LONG-ACTING; INSULIN, REGULAR, HUMAN; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PATIENT DROPOUTS; SODIUM; TIME FACTORS; WATER-ELECTROLYTE BALANCE; WEIGHT LOSS;

EID: 84856702104     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2345-8     Document Type: Article

References (11)

1. Hermansen K, Davies M, Derezinski T, Ravn GM, Clauson P, Home P (2006) A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naïve people with type 2 diabetes. Diabetes Care 29:1269-1274 (Pubitemid 44125921)
2. Philis-Tsimikas A, Charpentier G, Clauson P, Ravn GM, Roberts VL, Thorsteinsson B (2006) Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes. Clin Ther 28:1569-1581 (Pubitemid 44856694)
3. Russell-Jones D, Khan R (2007) Insulin-associated weight gain in diabetes: causes, effects and coping strategies. Diabetes Obes Metab 9:799-812 (Pubitemid 47555203)
4. Hordern SV,Wright JE, Umpleby AM, Shojaee-Moradia F, Amiss J, Russell-Jones DL (2005) Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp. Diabetologia 48:420-426 (Pubitemid 40487287)
5. Nørgård K, Jensen T, Skøtt P et al (1991) Effect of insulin on renal haemodynamics and sodium handling in healthy subjects. Scand J Clin Lab Invest 51:367-376
6. Feldt-Rasmussen B, Mathiesen ER, Deckert T et al (1987) Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:610-616
7. Skott P, Hother-Nielsen O, Bruun NE et al (1989) Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 32:694-699 (Pubitemid 19235997)
8. Stenvinkel P, Bolinder J, Alvestrand A (1992) Effects of insulin on renal hemodynamics and the proximal and distal tubular sodium handling in healthy subjects. Diabetologia 35:1042-1048
9. WHO Consultation Report (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1, pp 1-49
10. Zanchi A, Maillard M, Jornayvaz FR et al (2010) Effects of peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals. Diabetologia 53:1568-1575
11. Gerich JE (2010) Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet Med 27:136-142